newsfilter
← Latest News
PR Newswire·

Tetra Bio-Pharma Signs License Agreement with Thorne for a Prebiotic Dietary Supplement

OTTAWA, ON, Feb. 22, 2022 /PRNewswire/ - Tetra Bio-Pharma Inc ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development, today announced it has signed a Licensing Agreement with Thorn